Skip to Content

Delstrigo Prices, Coupons and Patient Assistance Programs

Delstrigo (doravirine/lamivudine/tenofovir) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.

Delstrigo Prices

This Delstrigo price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Delstrigo oral tablet (100 mg-300 mg-300 mg) is around $2,312 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Delstrigo is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Delstrigo availability.

Oral Tablet

100 mg-300 mg-300 mg Delstrigo oral tablet
from $2,311.52 for 30 tablet
Quantity Per unit Price
30 $77.05 $2,311.52

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Delstrigo Coupons and Rebates

Delstrigo offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Delstrigo Savings Coupon: Eligible patients may a maximum of $6800 on 12 prescriptions; coupon may be redeemed once every 21 days; for additional information contact program at 800-672-6372.

Applies to:Delstrigo
Number of uses:12 times
ExpiresDecember 31, 2020

Patient Assistance Programs for Delstrigo

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Merck Patient Assistance Program

Elligibility requirements:

  1. Determined case by case
  2. At or below 400% of FPL
  3. Not specified
  4. Must be residing in the US or a US territory, and under the care of a US physician
  5. At Merck we realize that sometimes exceptions need to be made based on the patient's individual circumstances. Individuals who do not meet the insurance criteria may still qualify for the Merck Patient Assistance Program if they attest that they have special circumstances of financial hardship, and their income meets the program criteria. *The Enrollment Form must be mailed. Please do not fax. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) Tablet

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) Tablet

Provider: Merck Connect

Elligibility requirements:

  1. Determined case by case
  2. Not disclosed
  3. Medically Necessary as determined by a Doctor
  4. Must be treated by US licensed healthcare provider
  5. Resources for HEALTHCARE PROFESSIONALS ONLY. The Physician must register to access tools and materials for patient support, product sample requests, up-to-date professional resources, and other Merck professional sites.

Applicable drugs:

  • Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) Tablet

Provider: Good Days Program

Elligibility requirements:

  1. Must have insurance
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be a US resident with a Social Security Number.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Applicable drugs:

  • Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) Tablet

Provider: HarborPath ADAP Waiting List Program

Elligibility requirements:

  1. Must be uninsured
  2. Determined case by case
  3. Medically appropriate condition/diagnosis
  4. The patient must also be a US resident.
  5. Resources for HEALTHCARE PROFESSIONALS ONLY. Patients are eligible for the HarborPath ADAP Waiting List Program if they: Meet eligibility for the ADAP Waiting List Program in their state of residency; and have a confirmation letter from their state ADAP indicating patient is on the ADAP waiting list. Typical eligibility requirements do not apply to the ADAP Waiting List Program.

Applicable drugs:

  • Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) Tablet
Hide